Shares of RTW Biotech Opportunities (LON:RTW - Get Free Report) dropped 0.7% on Wednesday . The company traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.40 ($0.02). Approximately 21,838 shares changed hands during trading, a decline of 93% from the average daily volume of 304,133 shares. The stock had previously closed at GBX 1.41 ($0.02).
RTW Biotech Opportunities Price Performance
The stock has a market capitalization of £470.28 million, a price-to-earnings ratio of 3.34 and a beta of 0.60. The business's 50-day simple moving average is GBX 1.28 and its two-hundred day simple moving average is GBX 1.24.
About RTW Biotech Opportunities
(
Get Free Report)
RTW Biotech Opportunities Ltd LSE: RTW is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
See Also
Before you consider RTW Biotech Opportunities, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RTW Biotech Opportunities wasn't on the list.
While RTW Biotech Opportunities currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access